MedTrace Logo

Ultrasound-assessed Internal Jugular Vein Distensibility in Advanced Chronic Heart Failure (US-IJVD in CHF)

NCT03874312 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-03-21

No results posted yet for this study

Summary

Prospective validation of the ultrasound-assessed internal jugular vein distensibility (JVD) ratio to identify patients with systolic chronic heart failure and right atrial pressure (RAP) of 7 or less mmHg measured by the right heart catheterization. In a calibration cohort, a threshold ratio will be identified, above which the RAP is normal with the highest accuracy. This diagnostic tool with a defined threshold of the JVD ratio will be assessed in a second prospective validation cohort.

Conditions

  • Systolic Chronic Heart Failure
  • Congestion, Venous
  • Advanced Heart Failure

Interventions

DIAGNOSTIC_TEST

Linear ultrasound (US) assessment of the internal jugular vein

Evaluation of jugular vein distensibility at rest and after Valsalva maneuver by US at the time of the RHC. US-guided IJV is routinely performed at the time of vein cannulation.

Sponsors & Collaborators

  • Niguarda Hospital

    lead OTHER

Principal Investigators

  • Enrico Ammirati, MD, PhD · Niguarda Hospital, Milano, Italy

  • Fabrizio Oliva, MD · Niguarda Hospital, Milano, Italy

  • Davide Marchetti, MD · Università Statale di Milano, Italy

  • Andrea Garascia, MD · Niguarda Hospital, Milano, italy

  • Giada Colombo · Università Statale di Milano, Italy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-18
Primary Completion
2019-02-27
Completion
2022-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03874312 on ClinicalTrials.gov